Möjlig interaktion mellan probiotika och warfarin

Lakartidningen

Volumn 107, Issue 13, 2010, Pages 917-

  Lindh, Jonatan ^a  

^a Karolic   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; PROBIOTIC AGENT; VITAMIN K GROUP; WARFARIN;

ANIMAL; ARTICLE; BACTERIUM; BIFIDOBACTERIUM; BIOSYNTHESIS; DRUG INTERACTION; FOOD DRUG INTERACTION; HUMAN; INTESTINE; LACTOBACILLUS RHAMNOSUS; METABOLISM; MICROBIOLOGY;

ANIMALS; ANTICOAGULANTS; BACTERIA; BIFIDOBACTERIUM; DRUG INTERACTIONS; FOOD-DRUG INTERACTIONS; HUMANS; INTESTINES; LACTOBACILLUS RHAMNOSUS; PROBIOTICS; VITAMIN K; WARFARIN;

EID: 77950238399     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Produktresumé Bifolac, Läkemedelsverkets webbplats [citerat 17 februari 2009]. Tillgängligt via: http://www.lakemedelsverket.se
2. Bentley R, Meganathan R. Biosynthesis of vitamin K (menaquinone) in bacteria. Microbiol Rev. 1982;46(3):241-80.
3. Resta SC. Effects of probiotics and commensals on intestinal epithelial physiology: implications for nutrient handling. J Physiol. 2009;587(Pt 17):4169-74.
4. Kindberg C, Suttie JW, Uchida K, Hirauchi K, Nakao H. Menaquinone production and utilization in germ-free rats after inoculation with specific organisms. J Nutr. 1987;117(6):1032-5.
5. Hojo K, Nagaoka S, Murata S, Taketomo N, Ohshima T, Maeda N. Reduction of vitamin K concentration by salivary Bifidobacterium strains and their possible nutritional competition with Porphyromonas gingivalis. J Appl Microbiol. 2007;103(5):1969-974.